GLPwatch
Trials (2139)
Page 15 of 36.
- Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
- A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes
- Role of Exenatide in NASH-a Pilot Study
- Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
- The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
- Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
- Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
- The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
- A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma
- The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
- A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment
- Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
- A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
- 2024 Tirzepatide-Bariatric Surgery
- A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
- A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
- Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
- Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
- A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight
- Anti-obesity Pharmacotherapy and Inflammation
- A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus
- Liraglutide Effect in Atrial Fibrillation
- Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
- A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term
- A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
- Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects
- Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
- Incretin-based Drugs and the Risk of Heart Failure
- GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
- A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes
- A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
- Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults
- A Study of IBI362 in Participants With Obesity or Overweight
- Study of Tirzepatide in Healthy Participants
- A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
- QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy
- Real-World Tirzepatide Therapy in Post-Bariatric Weight Regain and Preoperative Obesity Patients
- Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
- A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants
- GENETIC VARIABILITY TO GLP1 TREATMENT
- Semaglutide Therapy for Alcohol Reduction - Tulsa
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
- Digital Physical Activity Program
- A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
- SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
- Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.
- Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
- A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
- Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
- A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
- A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants
- Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients